Overview

Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
0
Participant gender:
All
Summary
Epidemiological study of Ozurdex® in sites treating patients with retinal vein occlusion.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Criteria
Inclusion Criteria:

- Macular oedema due to retinal vein occlusion

Exclusion Criteria:

- Not living in metropolitan France